DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
70	広範脊柱管狭窄症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04007094 (ClinicalTrials.gov)	February 12, 2019	24/4/2019	Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery	A Prospective, Single Arm Study of Patients Undergoing Posterolateral Lumbar Fusion (Without Interbody) Supplemented With ViviGen Cellular Bone Matrix	Degenerative Disc Disease;Spinal Stenosis;Spondylosis;Spondylolisthesis	Drug: ViviGen Cellular Bone Matrix	Ohio State University	DePuy Synthes	Recruiting	18 Years	N/A	All	50	Phase 4	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04007094
(ClinicalTrials.gov)

February 12, 2019

24/4/2019

Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery

A Prospective, Single Arm Study of Patients Undergoing Posterolateral Lumbar Fusion (Without Interbody) Supplemented With ViviGen Cellular Bone Matrix

Degenerative Disc Disease;Spinal Stenosis;Spondylosis;Spondylolisthesis

Drug: ViviGen Cellular Bone Matrix

Ohio State University

DePuy Synthes

Recruiting

18 Years

N/A

All

Phase 4

United States